Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Shield Therapeutics PLC on Thursday said it remains on track to meet its full-year revenue covenant target following ...
Shield Therapeutics PLC 21 November 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Business Update Recruitment completed of the Phase 3 confirmatory Study in...
Shield Therapeutics PLC on Tuesday said it has strengthened its financial foundation in the hope of becoming cash flo ...
Shield Therapeutics PLC 29 October 2024 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...
Shield Therapeutics PLC 25 September 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Results from Phase 3 paediatric study Pivotal Trial of ACCRUFeR®/FeRACCRU®...
Shield Therapeutics PLC said on Wednesday that its revenue had multiplied threefold, but an increased cost of sales a ...
Shield Therapeutics PLC 04 September 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Interim results for the six months ended 30 June 2024 More than threefold...
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...
Shield Therapeutics PLC 27 August 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") ACCRUFeR® Approved by Health Canada ACCRUFeR® is the only oral iron therapy...
Shield Therapeutics PLC 14 August 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Notice of interim results London, UK, 14 August 2024: Shield Therapeutics plc...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 2.85 | 2.9 | 2.75 | 437969 | 2.87099896 | DE |
| 4 | 0.05 | 1.78571428571 | 2.8 | 3.35 | 2.625 | 3378219 | 2.87233311 | DE |
| 12 | -2.25 | -44.1176470588 | 5.1 | 5.1 | 2.625 | 3080998 | 3.60349314 | DE |
| 26 | 0.8 | 39.0243902439 | 2.05 | 5.8 | 1.525 | 3861533 | 3.38871876 | DE |
| 52 | -3.45 | -54.7619047619 | 6.3 | 7.65 | 1.075 | 4358082 | 3.15881968 | DE |
| 156 | -29.65 | -91.2307692308 | 32.5 | 51 | 1.075 | 2561833 | 5.92014453 | DE |
| 260 | -190.15 | -98.5233160622 | 193 | 195 | 1.075 | 1807639 | 13.77024522 | DE |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
